Association between IPS-1 polymorphisms and PEG-IFN treatment response in patients with HBeAg-positive chronic hepatitis B

ObjectiveTo investigate whether interferon-β promoter stimulator 1 (IPS-1) gene polymorphisms could affect the treatment response to peginterferon alpha (PEG-IFN) in patients with HBeAg-positive chronic hepatitis B (CHB). MethodsA total of 212 HBeAg-positive CHB patients treated with PEG-IFN monothe...

Full description

Bibliographic Details
Main Author: WU Haiqing
Format: Article
Language:zho
Published: Editorial Department of Journal of Clinical Hepatology 2014-08-01
Series:Linchuang Gandanbing Zazhi
Subjects:
Online Access:http://www.lcgdbzz.org/qk_content.asp?id=6026&ClassID=6261339